Solitary Inhibition of the Breast Cancer Resistance Protein (BCRP) Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing Up To a Two-Fold Increase in Statin Exposure
Elsby, R., Martin, P. D., Surry, D., Sharma, P., Fenner, K.Language:
english
Journal:
Drug Metabolism and Disposition
DOI:
10.1124/dmd.115.066795
Date:
December, 2015
File:
PDF, 388 KB
english, 2015